4//SEC Filing
Burgess Julie 4
Accession 0001209191-21-059038
CIK 0001807120other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:53 PM ET
Size
5.5 KB
Accession
0001209191-21-059038
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2021-10-01+135,000→ 135,000 totalExercise: $14.99Exp: 2031-09-30→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest one year after September 13, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001883722
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:53 PM ET
- Size
- 5.5 KB